Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Erector spinae plane block versus intrathecal morphine for recovery after cesarean

Official title: Comparison of Erector Spinae Plane Block and Intrathecal Morphine for Assessements of Quality of Recovery After Caesarean Section: a Randomized Controlled Trial

Run by AUSL Romagna Rimini · NCT07202416 · Data updated 2026-11-12

This will test whether a postoperative erector spinae plane (ESP) block or intrathecal morphine helps women recover better after an elective cesarean delivery.

More Post Operative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment52 (estimated)
SponsorAUSL Romagna Rimini
Academic / other
Locations1 site (Cesena, Forlì)
StatusRecruiting
StartedJune 18, 2025
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedOctober 1, 2025
Trial IDNCT07202416 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women aged 18–45 with ASA II–III, full-term singleton pregnancy scheduled for elective cesarean under spinal anesthesia who can consent and use verbal pain scales are ideal candidates.

Probably not a fit

Patients having emergency cesarean, with coagulation disorders, chronic opioid use, allergies to study drugs, contraindications to neuraxial techniques, or inability to use pain scales are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective interventional study compares postoperative ESP block with intrathecal morphine for analgesia after elective cesarean section in adult women. Participants who meet inclusion criteria will be assigned to receive either a postoperative ESP block or intrathecal morphine as part of a multimodal analgesic protocol. The primary outcome is quality of recovery measured by the validated QoR-11 questionnaire, with secondary outcomes including pain scores, opioid consumption, opioid-related side effects, time to mobilization, breastfeeding outcomes, and length of hospital stay. Safety exclusions include coagulation disorders, infection at the puncture site, contraindications to neuraxial analgesia, chronic opioid use, and other standard perioperative contraindications.

Why it matters

Potential benefit: If successful, this approach could improve postoperative recovery and reduce opioid-related side effects after cesarean delivery.

How similar studies have gone: Intrathecal morphine is an established method for cesarean analgesia, while ESP block has shown promising but still limited and mixed evidence in obstetric settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult women aged 18-45 years
* ASA physical status II-III
* Full-term singleton pregnancy scheduled for elective cesarean section under spinal anesthesia

Exclusion Criteria:

* ASA ≥ IV
* Coagulation disorders
* Emergency surgery
* Preoperative infection (including infection at the ESPB puncture site)
* Any contraindication to neuraxial analgesia
* History of chronic pain
* Use of opioids
* Allergy to local anesthetics
* Hypersensitivity to any drug used in the study
* Inability to understand or use verbal pain assessment scales
* Refusal to participate in the study

Where it's running

  • AUSL Romagna - Ospedale M.Bufalini
    Cesena, Forlì, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.